• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舒必利治疗急性躁狂症,并比较锂盐和舒必利治疗对血浆激素浓度的影响。

Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment.

作者信息

Christie J E, Whalley L J, Hunter R, Bennie J, Fink G

机构信息

MRC Brain Metabolism Unit, Royal Edinburgh Hospital, U.K.

出版信息

J Affect Disord. 1989 Mar-Jun;16(2-3):115-20. doi: 10.1016/0165-0327(89)90064-5.

DOI:10.1016/0165-0327(89)90064-5
PMID:2522110
Abstract

Sulpiride, in this open study of acute manic patients, had a clear antimanic action with all eight patients responding to sulpiride treatment without the need for other antipsychotic drugs. Plasma prolactin concentrations were increased and oestrogen-stimulated neurophysin concentrations decreased by sulpiride but were unchanged by lithium treatment, whereas TSH concentrations showed a rapid increase following the introduction of lithium therapy.

摘要

在这项针对急性躁狂症患者的开放性研究中,舒必利对所有八名患者均有明显的抗躁狂作用,这些患者对舒必利治疗有反应,无需使用其他抗精神病药物。舒必利可使血浆催乳素浓度升高,雌激素刺激的神经垂体素浓度降低,而锂治疗对此无影响,而在开始锂治疗后促甲状腺激素浓度迅速升高。

相似文献

1
Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment.舒必利治疗急性躁狂症,并比较锂盐和舒必利治疗对血浆激素浓度的影响。
J Affect Disord. 1989 Mar-Jun;16(2-3):115-20. doi: 10.1016/0165-0327(89)90064-5.
2
Luteinizing hormone responses to luteinizing hormone releasing hormone (LHRH) in acute mania and the effects of lithium on LHRH and thyrotrophin releasing hormone tests in volunteers.急性躁狂症患者对促黄体生成素释放激素(LHRH)的促黄体生成素反应以及锂对志愿者LHRH和促甲状腺激素释放激素试验的影响。
Psychol Med. 1989 Feb;19(1):69-77. doi: 10.1017/s003329170001103x.
3
Disturbed endocrine function in the psychoses. II: Discriminant function analysis of multihormone data.
Br J Psychiatry. 1989 Oct;155:462-7. doi: 10.1192/bjp.155.4.462.
4
Characteristic plasma hormone changes in Alzheimer's disease.阿尔茨海默病中典型的血浆激素变化。
Br J Psychiatry. 1987 May;150:674-81. doi: 10.1192/bjp.150.5.674.
5
Effects of chronic sultopride treatment on endocrine systems in psychotic women.舒托必利长期治疗对精神病女性内分泌系统的影响。
Psychopharmacology (Berl). 1984;82(4):287-90. doi: 10.1007/BF00427671.
6
Plasma concentrations of cortisol, prolactin, luteinizing hormone, and follicle-stimulating hormone in stallions after physical exercise and injection of secretagogue before and after sulpiride treatment in winter.冬季,在舒必利治疗前后,对公马进行体育锻炼并注射促分泌素后,其血浆中皮质醇、催乳素、促黄体生成素和促卵泡激素的浓度。
J Anim Sci. 1991 Sep;69(9):3724-32. doi: 10.2527/1991.6993724x.
7
Selective effects of ECT on hypothalamic-pituitary activity.电休克疗法对下丘脑 - 垂体活动的选择性作用。
Psychol Med. 1987 May;17(2):319-28. doi: 10.1017/s0033291700024855.
8
Disturbed endocrine function in the psychoses. I: Disordered homeostasis or disease process?精神病中的内分泌功能紊乱。I:内稳态失调还是疾病过程?
Br J Psychiatry. 1989 Oct;155:455-61. doi: 10.1192/bjp.155.4.455.
9
Changes in plasma melanocyte-stimulating hormone, ACTH, prolactin, GH, LH, FSH, and thyroid-stimulating hormone in response to injection of sulpiride, thyrotropin-releasing hormone, or vehicle in insulin-sensitive and -insensitive mares.注射舒必利、促甲状腺素释放激素或载体后,胰岛素敏感和不敏感母马血浆中黑素细胞刺激素、ACTH、催乳素、GH、LH、FSH 和促甲状腺激素的变化。
Domest Anim Endocrinol. 2013 May;44(4):204-12. doi: 10.1016/j.domaniend.2013.03.001. Epub 2013 Mar 16.
10
The neuroendocrinology of mania.躁狂症的神经内分泌学
J Affect Disord. 1985 May-Jun;8(3):233-41. doi: 10.1016/0165-0327(85)90021-7.

引用本文的文献

1
Lithium for acute mania.用于急性躁狂症的锂盐。
Cochrane Database Syst Rev. 2019 Jun 1;6(6):CD004048. doi: 10.1002/14651858.CD004048.pub4.
2
Animal models for bipolar disorder: from bedside to the cage.双相情感障碍的动物模型:从床边到笼子
Int J Bipolar Disord. 2017 Oct 13;5(1):35. doi: 10.1186/s40345-017-0104-6.